Form 4 for INCY Incyte
Accepted 2022-04-12 00:00:00 ET · period of report 2022-04-08 · accession 0001209191-22-024136 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-12 | 2022-04-08 | INCY | Flannelly Barry P | EVP, General Manager US | S - Sale+OE | $83.49 | -44.0K | 65.2K | -40% | -$3.67M |
| DM | 2022-04-12 | 2022-04-08 | INCY | Flannelly Barry P | EVP, General Manager US | M - OptEx | $70.48 | +41.9K | 88.6K | +89% | +$2.95M |
| DM | 2022-04-12 | 2022-04-08 | INCY | Flannelly Barry P | EVP, General Manager US | M - OptEx | $0.00 | -41.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-08 | S | D | 21,348 | $84.00 | 67,292 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. |
| 2 | Common | Common Stock | 2022-04-08 | M | A | 20,516 | $68.62 | 87,808 | D | — | — | |
| 3 | Common | Common Stock | 2022-04-08 | S | D | 20,516 | $83.01 | 67,292 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. |
| 4 | Common | Common Stock | 2022-04-08 | M | A | 21,348 | $72.27 | 88,640 | D | — | — | |
| 5 | Common | Common Stock | 2022-04-08 | S | D | 881 | $82.96 | 66,411 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. |
| 6 | Common | Common Stock | 2022-04-08 | S | D | 1,248 | $82.96 | 65,163 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. (F2) Includes an aggregate of 64,148 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. |
| 7 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-04-08 | M | D | 20,516 | $0.00 | 0 | D | $68.62 · — to 2028-07-01 | 20,516 Common Stock | (F3) Beginning July 2, 2018, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years. |
| 8 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-04-08 | M | D | 21,348 | $0.00 | 0 | D | $72.27 · — to 2029-01-03 | 21,348 Common Stock | (F4) Beginning January 4, 2019, options become exercisable in 37 installments, with the first 25% vesting on July 2, 2019 and the remainder vesting monthly over three years. |